Jason Matthew Elliott

Person

Felsted, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Tetrahydropyran compounds as tachykinin antagonists
- Patent number 7,393,858
- Issue date Jul 1, 2008
- Merck Sharp & Dohme Ltd.
- Olivier Dirat
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Gem-disubstituted cyclohexane derivatives and their use as therapeu...
- Patent number 7,253,205
- Issue date Aug 7, 2007
- Merck Sharp & Dohme Limited
- Jose Luis Castro Pineiro
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sulphones for inhibition of gamma secretase
- Patent number 7,161,006
- Issue date Jan 9, 2007
- Merck Sharp & Dohme Limited
- James Michael Crawforth
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclohexane derivatives and their use as therapeutic agents
- Patent number 7,105,507
- Issue date Sep 12, 2006
- Merck Sharp & Dohme Limited
- Jose Luis Castro Pineiro
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of NK-1 receptor antagonists for treating major depressive diso...
- Patent number 6,613,765
- Issue date Sep 2, 2003
- Merck Sharp & Dohme Limited
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2-aryl indole derivative as antagonists of tachykinins
- Patent number 6,518,273
- Issue date Feb 11, 2003
- Merck Sharp & Dohme Ltd.
- Kevin Tyler Chapman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Azaindole derivatives and their use as therapeutic agents
- Patent number 6,476,045
- Issue date Nov 5, 2002
- Merck Sharp & Dohme Ltd.
- Kevin Dinnell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of NK-1 receptor antagonists for treating cognitive disorders
- Patent number 6,271,230
- Issue date Aug 7, 2001
- Merck Sharp & Dohme Limited
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted 3-(benzylamino)piperidine derivatives and their use as...
- Patent number 6,214,846
- Issue date Apr 10, 2001
- Merck Sharp & Dohme Limited
- Jason Matthew Elliott
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Spiro-azacyclic derivatives and their use as therapeutic agents
- Patent number 6,172,077
- Issue date Jan 9, 2001
- Merck Sharp & Dohme Ltd.
- Neil Roy Curtis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spiro-ketal derivatives and their use as therapeutic agents
- Patent number 6,127,365
- Issue date Oct 3, 2000
- Merck Sharp & Dohme Ltd.
- Jason Matthew Elliott
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of NK-1 receptor antagonists for treating major depressive diso...
- Patent number 6,114,315
- Issue date Sep 5, 2000
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptors antagonists for treating schizophrenic disorders
- Patent number 6,100,256
- Issue date Aug 8, 2000
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
3-benzylaminopiperidines as tachykinin receptor antagonists
- Patent number 6,096,766
- Issue date Aug 1, 2000
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of NK-1 receptor antagonists for treating amnestic disorders
- Patent number 6,096,729
- Issue date Aug 1, 2000
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptor antagonists for treating stress disorders
- Patent number 6,087,348
- Issue date Jul 11, 2000
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Spiro-piperidine derivatives and their use as therapeutic agents
- Patent number 6,071,927
- Issue date Jun 6, 2000
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Piperidine and morpholine derivatives and their use as therapeutic...
- Patent number 5,985,896
- Issue date Nov 16, 1999
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of NK-1 receptor antagonists for treating bipolar disorders
- Patent number 5,977,104
- Issue date Nov 2, 1999
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptor antagonists for treating bipolar disorders
- Patent number 5,952,315
- Issue date Sep 14, 1999
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptor antagonists for treating sexual dysfunctions
- Patent number 5,929,054
- Issue date Jul 27, 1999
- Merck Sharp
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptor antagonists for treating movement disorders
- Patent number 5,925,627
- Issue date Jul 20, 1999
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptor antogonists for treating substance use disorders
- Patent number 5,919,781
- Issue date Jul 6, 1999
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Serine derivatives and their use as therapeutic agents
- Patent number 5,885,999
- Issue date Mar 23, 1999
- Merck Sharp & Dohme Ltd.
- Jason Matthew Elliott
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperidine and morphonline derivatives and their use as therapeutic...
- Patent number 5,830,892
- Issue date Nov 3, 1998
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Quinoline derivatives as neurokinin receptor antagonists
- Publication number 20090054440
- Publication date Feb 26, 2009
- William Robert Carling
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Quinoline Derivatives as Neurokinin Receptor Antagonists
- Publication number 20080096885
- Publication date Apr 24, 2008
- William Robert Carling
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Tetrahydropyran compounds as tachykinin antagonists
- Publication number 20060172999
- Publication date Aug 3, 2006
- Olivier Dirat
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Tetrahydropyran derivatives and their use as therapeutic agents
- Publication number 20050261285
- Publication date Nov 24, 2005
- Olivier Dirat
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel sulphones for inhibition of gamma secretase
- Publication number 20050261276
- Publication date Nov 24, 2005
- James Michael Crawforth
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Gem-disubstituted cyclohexane derivatives and their use as therapeu...
- Publication number 20040171642
- Publication date Sep 2, 2004
- Jose Luis Castro Pineiro
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cyclohexane derivatives and their use as therapeutic agents
- Publication number 20030236250
- Publication date Dec 25, 2003
- Jose Luis Castro Pineiro
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cyclohexyl derivatives and their use as therapeutic agents
- Publication number 20030225059
- Publication date Dec 4, 2003
- Jose Luis Castro Pineiro
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Azaindole derivatives and their use as therapeutic agents
- Publication number 20020022624
- Publication date Feb 21, 2002
- Kevin Dinnell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2-aryl indole derivatives and their use as therapeutic agents
- Publication number 20010039286
- Publication date Nov 8, 2001
- Kevin Dinnell
- C07 - ORGANIC CHEMISTRY

Jason Matthew Elliott

Person

Patents Grantslast 30 patents

Tetrahydropyran compounds as tachykinin antagonists

Gem-disubstituted cyclohexane derivatives and their use as therapeu...

Sulphones for inhibition of gamma secretase

Cyclohexane derivatives and their use as therapeutic agents

Use of NK-1 receptor antagonists for treating major depressive diso...

2-aryl indole derivative as antagonists of tachykinins

Azaindole derivatives and their use as therapeutic agents

Use of NK-1 receptor antagonists for treating cognitive disorders

Substituted 3-(benzylamino)piperidine derivatives and their use as...

Spiro-azacyclic derivatives and their use as therapeutic agents

Spiro-ketal derivatives and their use as therapeutic agents

Use of NK-1 receptor antagonists for treating major depressive diso...

Use of NK-1 receptors antagonists for treating schizophrenic disorders

3-benzylaminopiperidines as tachykinin receptor antagonists

Use of NK-1 receptor antagonists for treating amnestic disorders

Use of NK-1 receptor antagonists for treating stress disorders

Spiro-piperidine derivatives and their use as therapeutic agents

Piperidine and morpholine derivatives and their use as therapeutic...

Use of NK-1 receptor antagonists for treating bipolar disorders

Use of NK-1 receptor antagonists for treating bipolar disorders

Use of NK-1 receptor antagonists for treating sexual dysfunctions

Use of NK-1 receptor antagonists for treating movement disorders

Use of NK-1 receptor antogonists for treating substance use disorders

Serine derivatives and their use as therapeutic agents

Piperidine and morphonline derivatives and their use as therapeutic...

Patents Applicationslast 30 patents

Quinoline derivatives as neurokinin receptor antagonists

Quinoline Derivatives as Neurokinin Receptor Antagonists

Tetrahydropyran compounds as tachykinin antagonists

Tetrahydropyran derivatives and their use as therapeutic agents

Novel sulphones for inhibition of gamma secretase

Gem-disubstituted cyclohexane derivatives and their use as therapeu...

Cyclohexane derivatives and their use as therapeutic agents

Cyclohexyl derivatives and their use as therapeutic agents

Azaindole derivatives and their use as therapeutic agents

2-aryl indole derivatives and their use as therapeutic agents